Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1981
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1991 1
1994 1
1995 1
2001 1
2003 1
2011 1
2013 2
2014 1
2015 2
2016 1
2017 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Gynecological sarcomas.
DiSaia PJ, Pecorelli S. DiSaia PJ, et al. Semin Surg Oncol. 1994 Sep-Oct;10(5):369-73. doi: 10.1002/ssu.2980100510. Semin Surg Oncol. 1994. PMID: 7997731 Review.
Sarcomas of the uterus, ovary and lower genital tract are fortunately rare, since the prognosis is quite often poor. The most frequent are sarcomas of the uterine corpus, and these account for only 4% of all uterine tumors. Ovarian sarcomas are less fr …
Sarcomas of the uterus, ovary and lower genital tract are fortunately rare, since the prognosis is quite often poor. The most frequen …
Uterine leiomyosarcoma: a review article.
Gockley AA, Rauh-Hain JA, del Carmen MG. Gockley AA, et al. Int J Gynecol Cancer. 2014 Nov;24(9):1538-42. doi: 10.1097/IGC.0000000000000290. Int J Gynecol Cancer. 2014. PMID: 25304676 Review.
Uterine leiomyosarcomas (LMSs) are rare aggressive tumors, with high recurrence rates, even when confined to the uterine corpus at the time of diagnosis. ...
Uterine leiomyosarcomas (LMSs) are rare aggressive tumors, with high recurrence rates, even when confined to the uterine co
Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O. Fadare O. Adv Anat Pathol. 2011 Jan;18(1):60-74. doi: 10.1097/PAP.0b013e3182026be7. Adv Anat Pathol. 2011. PMID: 21169739 Review.
Pure sarcomas of the uterine corpus are uncommon, constituting less than 3% of all malignancies at this site, and most of them are leiomyosarcomas and endometrial stromal sarcomas. ...In this article, the clinicopathologic attributes of all earlier reported sarcomas …
Pure sarcomas of the uterine corpus are uncommon, constituting less than 3% of all malignancies at this site, and most of them …
Malignant tumors of the uterine corpus: molecular background of their origin.
Brany D, Dvorska D, Nachajova M, Slavik P, Burjanivova T. Brany D, et al. Tumour Biol. 2015 Sep;36(9):6615-21. doi: 10.1007/s13277-015-3824-1. Epub 2015 Aug 26. Tumour Biol. 2015. PMID: 26307392 Review.
Tumors of the uterine corpus can be divided into two main groups: endometrial tumors and mesenchymal tumors. ...This view includes a different expression pattern of genes, usually aberrant in cases of uterine cancer that can arise due to epigenetic modificati …
Tumors of the uterine corpus can be divided into two main groups: endometrial tumors and mesenchymal tumors. ...This view incl …
Major clinical research advances in gynecologic cancer in 2015.
Suh DH, Kim M, Kim HJ, Lee KH, Kim JW. Suh DH, et al. J Gynecol Oncol. 2016 Nov;27(6):e53. doi: 10.3802/jgo.2016.27.e53. J Gynecol Oncol. 2016. PMID: 27775259 Free PMC article. Review.
For cervical cancer, update of human papillomavirus vaccines regarding two-dose regimen, 9-valent vaccine, and therapeutic vaccine was reviewed. For corpus cancer, the safety concern of power morcellation in presumed fibroids was explored again with regard to age and preva …
For cervical cancer, update of human papillomavirus vaccines regarding two-dose regimen, 9-valent vaccine, and therapeutic vaccine was revie …
Major clinical research advances in gynecologic cancer in 2014.
Suh DH, Lee KH, Kim K, Kang S, Kim JW. Suh DH, et al. J Gynecol Oncol. 2015 Apr;26(2):156-67. doi: 10.3802/jgo.2015.26.2.156. J Gynecol Oncol. 2015. PMID: 25872896 Free PMC article. Review.
In 2014, 9 topics were selected as major advances in clinical research for gynecologic oncology: 2 each in cervical and corpus cancer, 4 in ovarian cancer, and 1 in breast cancer. For cervical cancer, several therapeutic agents showed viable antitumor clinical response in …
In 2014, 9 topics were selected as major advances in clinical research for gynecologic oncology: 2 each in cervical and corpus cancer …
Recent Developments in Surgical Pathology of the Uterine Corpus.
Hanley KZ, Birdsong GG, Mosunjac MB. Hanley KZ, et al. Arch Pathol Lab Med. 2017 Apr;141(4):528-541. doi: 10.5858/arpa.2016-0284-SA. Epub 2017 Feb 28. Arch Pathol Lab Med. 2017. PMID: 28353387 Free article. Review.
There have been several updates recently on the classification of uterine tumors. Endometrial carcinomas have traditionally been divided into 2 types, but some are difficult to classify and do not fit readily into either of the currently recognized categories. ...The new d …
There have been several updates recently on the classification of uterine tumors. Endometrial carcinomas have traditionally been divi …
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052).
Asano H, Oda K, Yoshihara K, Ito YM, Matsumura N, Shimada M, Watari H, Enomoto T. Asano H, et al. J Gynecol Oncol. 2022 Jul;33(4):e55. doi: 10.3802/jgo.2022.33.e55. Epub 2022 May 3. J Gynecol Oncol. 2022. PMID: 35557035 Free PMC article. Review.
Genomic analysis revealed that about 20% of uterine leiomyosarcoma (uLMS) have HRD, including 7.5%-10% of BRCA1/2 alterations and 4%-6% of carcinomas of the uterine corpus, and 2.5%-4% of the uterine cervix have alterations of BRCA1/2. ...
Genomic analysis revealed that about 20% of uterine leiomyosarcoma (uLMS) have HRD, including 7.5%-10% of BRCA1/2 alterations …
Unusual types of smooth muscle tumors of uterine corpus: case reports and literature review.
Makharoblidze E, Goishvili N, Mchedlishvili M, Khakhutaishvili I, Jangavadze M. Makharoblidze E, et al. Georgian Med News. 2013 Mar;(216):7-11. Georgian Med News. 2013. PMID: 23567300 Review.
We report three cases of unusual types of smooth muscle tumors of uterine corpus: 1) highly cellular leiomyoma; 2) cotyledonoid dissecting leiomyoma (CDL) and 3) poorly differentiated leiomyosarcoma. Diagnostic pathology of the uterine smooth muscle tu …
We report three cases of unusual types of smooth muscle tumors of uterine corpus: 1) highly cellular leiomyoma; 2) cotyledonoi …
Carcinosarcoma of the corpus uteri (Malignant Mullerian Mixed Tumor): a case report in Yaounde (Cameroon).
Sando Z, Fouelifack FY, Fouogue JT, Fouedjio JH, Anoudem CE, Nangue C. Sando Z, et al. Pan Afr Med J. 2013 Dec 19;16:145. doi: 10.11604/pamj.2013.16.145.3497. eCollection 2013. Pan Afr Med J. 2013. PMID: 24876903 Free PMC article. Review.
Carcinosarcoma of the uterus is a rare tumor representing 2-4% of uterine malignancies. Its prognosis is poor with a 5 years survival rate of 10-30%. ...The preoperative biopsy of endometrium revealed a leiomyosarcoma. Total body Computerized Tomography (CT) …
Carcinosarcoma of the uterus is a rare tumor representing 2-4% of uterine malignancies. Its prognosis is poor with a 5 years s …
15 results